Literature DB >> 30466767

Newborn Screening for Severe Combined Immunodeficiency in the United States: Lessons Learned.

Morna J Dorsey1, Jennifer M Puck2.   

Abstract

In the United States, significant improvement in diagnosis and outcomes for children affected with severe combined immunodeficiency has followed institution of newborn screening using an assay to measure T-cell receptor excision circles in newborn dried blood spot specimens. Key to this outcome is the avoidance of infectious complications in infants with severe combined immunodeficiency.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematopoietic cell transplant (HCT); Newborn screen (NBS); Severe combined immunodeficiency (SCID); T-cell lymphopenia; T-cell receptor excision circles (TRECs)

Mesh:

Substances:

Year:  2018        PMID: 30466767     DOI: 10.1016/j.iac.2018.08.002

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  8 in total

1.  Severe Combined Immunodeficiency (SCID) Screening in Arizona: Lessons Learned from the First 2 Years.

Authors:  Natalie A Booth; Catherine M Freeman; Benjamin L Wright; Christine Rukasin; Priscila Badia; Michael Daines; Cindy S Bauer; Holly Miller
Journal:  J Clin Immunol       Date:  2022-06-22       Impact factor: 8.542

Review 2.  Achieving the Quadruple Aim to deliver value-based allergy care in an ever-evolving health care system.

Authors:  Edward G A Iglesia; Matthew Greenhawt; Marcus S Shaker
Journal:  Ann Allergy Asthma Immunol       Date:  2020-04-11       Impact factor: 6.347

3.  Abnormal Newborn Screening Follow-up for Severe Combined Immunodeficiency in an Amish Cohort with Cartilage-Hair Hypoplasia.

Authors:  Ethan M Scott; Sharat Chandra; Jinzhu Li; Eric D Robinette; Miraides F Brown; Olivia K Wenger
Journal:  J Clin Immunol       Date:  2020-01-06       Impact factor: 8.317

4.  Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network.

Authors:  Emilia Cirillo; Caterina Cancrini; Chiara Azzari; Silvana Martino; Baldassarre Martire; Andrea Pession; Alberto Tommasini; Samuele Naviglio; Andrea Finocchi; Rita Consolini; Paolo Pierani; Irene D'Alba; Maria Caterina Putti; Antonio Marzollo; Giuliana Giardino; Rosaria Prencipe; Federica Esposito; Fiorentino Grasso; Alessia Scarselli; Gigliola Di Matteo; Enrico Attardi; Silvia Ricci; Davide Montin; Fernando Specchia; Federica Barzaghi; Maria Pia Cicalese; Giuseppe Quaremba; Vassilios Lougaris; Silvia Giliani; Franco Locatelli; Paolo Rossi; Alessandro Aiuti; Raffaele Badolato; Alessandro Plebani; Claudio Pignata
Journal:  Front Immunol       Date:  2019-08-13       Impact factor: 7.561

5.  Screening for primary immunodeficiency diseases by next-generation sequencing in early life.

Authors:  Jinqiao Sun; Lin Yang; Yulan Lu; Huijun Wang; Xiaomin Peng; Xinran Dong; Guoqiang Cheng; Yun Cao; Bingbing Wu; Xiaochuan Wang; Wenhao Zhou
Journal:  Clin Transl Immunology       Date:  2020-05-17

Review 6.  Gene Therapies for Primary Immune Deficiencies.

Authors:  Lisa A Kohn; Donald B Kohn
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

7.  Comparison of dried blood spot and plasma sampling for untargeted metabolomics.

Authors:  Nicole H Tobin; Aisling Murphy; Fan Li; Sean S Brummel; Taha E Taha; Friday Saidi; Maxie Owor; Avy Violari; Dhayendre Moodley; Benjamin Chi; Kelli D Goodman; Brian Koos; Grace M Aldrovandi
Journal:  Metabolomics       Date:  2021-06-23       Impact factor: 4.747

Review 8.  A Critical Review on the Standardization and Quality Assessment of Nonfunctional Laboratory Tests Frequently Used to Identify Inborn Errors of Immunity.

Authors:  Sandro Félix Perazzio; Patricia Palmeira; Dewton Moraes-Vasconcelos; Andréia Rangel-Santos; João Bosco de Oliveira; Luis Eduardo Coelho Andrade; Magda Carneiro-Sampaio
Journal:  Front Immunol       Date:  2021-11-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.